Tetraneuron

Recent Finacing

Equity

Recent Raise

Undisclosed

Tetraneuron is a Madrid-based biotech developing an E2F4DN gene therapy (TET-101) that aims to restore neuronal homeostasis and halt Alzheimer’s disease progression.

Comunidad Valenciana, Spain

11-50

Private

tetraneuron.com